Last reviewed · How we verify
NCT02916199
Primary Needle Knife Fistulotomy Versus Conventional Cannulation Method
NA trial testing cannulation of ampulla of Vater in Common Bile Duct Stone in 207 participants. Completed in 28 November 2017.
28 November 2017
Quick facts
| Lead sponsor | Gangnam Severance Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 207 |
| Start date | 4 October 2016 |
| Primary completion | 28 November 2017 |
| Estimated completion | 28 November 2017 |
| Sites | 7 locations across South Korea |
Drugs / interventions tested
- cannulation of ampulla of Vater
Conditions studied
- Common Bile Duct Stone — all drugs for Common Bile Duct Stone →
- Malignant Hepatobiliary Neoplasm — all drugs for Malignant Hepatobiliary Neoplasm →
- Biliary Stricture — all drugs for Biliary Stricture →
- Pancreatic Diseases — all drugs for Pancreatic Diseases →
Sponsor
Gangnam Severance Hospital
Who can join
Adults 19 to 90, any sex, with Common Bile Duct Stone or Malignant Hepatobiliary Neoplasm. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study are to evaluate the feasibility of needle knife fistulotomy (NKF) as an initial procedure for biliary access in patients with biliary disease who are at increased risk for post-endoscopic retrograde endoscopic retrograde cholangiopancreatography (PEP) and to assess the incidence rate of complications including PEP between NKF and conventional cannulation methods.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Primary Needle-Knife Fistulotomy Versus Conventional Cannulation Method in a High-Risk Cohort of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis.
Jang SI, Kim DU, Cho JH, Jeong S, et al · · 2020 · cited 34× · PMID 31913191 · DOI 10.14309/ajg.0000000000000480
Verify or expand the search:
- PubMed search for NCT02916199
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Common Bile Duct Stone
Currently open trials in the same condition.
- NCT07368335 — Efficacy and Safety of a Novel ERCP Robot in the Treatment of Common Bile Duct Stone · NA · active not recruiting
Other Gangnam Severance Hospital trials
Trials by the same sponsor.
- NCT07505628 — AI-based Rehabilitation for Hip and Knee Surgery Patients · NA · not yet recruiting
- NCT07311122 — Endocrine Therapy Base on 21-gene RS · not yet recruiting
- NCT07011823 — Immune-checkpoint Blockade After Partial Breast Irradiation by Pembrolizumab in Early TNBC · Phase 2 · not yet recruiting
- NCT07211451 — Axillary Nodal Burden in HER2+ and TNBC · completed
- NCT06839716 — Comparison of Ropivacaine-Poloxamer 407 Hydrogel and TAP Block for Postoperative Pain Management in Laparoscopic/Robotic · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02916199 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Gangnam Severance Hospital
- Last refreshed: 30 January 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02916199.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing